Guest guest Posted April 1, 2005 Report Share Posted April 1, 2005 EDAP TMS, developer of Ablatherm, the most advanced and clinically proven choice for HIFU treatment, today welcomed the publication of the National Institute for Clinical Excellence (NICE) recent guidelines supporting the use of HIFU for the treatment of localized prostate cancer. 27,000 men in the UK are diagnosed with prostate cancer every year, and 10,000 die from the disease. http://www.nice.org.uk/page.aspx?o=80298 . Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.